BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Australian Diabetes Society - ECPv6.16.3//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-ORIGINAL-URL:https://www.diabetessociety.com.au
X-WR-CALDESC:Events for Australian Diabetes Society
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Australia/Sydney
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20240406T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20241005T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20250405T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20251004T160000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+1100
TZOFFSETTO:+1000
TZNAME:AEST
DTSTART:20260404T160000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+1000
TZOFFSETTO:+1100
TZNAME:AEDT
DTSTART:20261003T160000
END:DAYLIGHT
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Australia/Sydney:20250327T190000
DTEND;TZID=Australia/Sydney:20250327T200000
DTSTAMP:20260601T104805
CREATED:20250313T044356Z
LAST-MODIFIED:20250314T022555Z
UID:10000084-1743102000-1743105600@www.diabetessociety.com.au
SUMMARY:Updates on the Use of SGLT2i in Type 2 Diabetes Complications Management
DESCRIPTION:Join us on Thursday\, 27 March 2025 from 7:00 pm to 8:00 pm (AEDT) as we deliver an update on the role of SGLT2i in the management of type 2 diabetes and its complications. We will be reviewing the latest clinical evidence that has informed recent changes to reimbursement rules. \nThis webinar will cover: \n\nLatest clinical evidence for SGLT2i and type 2 diabetes\nThe use of SGLT2i in combination with other medications\nClinical considerations\nUpdate on adverse events and their management\n\nSpeakers\n \nClick here to view the event flyer.\nClick here to register for the webinar. \nFor any further information\, please contact the ADS Secretariat via email to ads@diabetessociety.com.au \n\n    The ADS gratefully acknowledges the support from AstraZeneca and Medi-Spec Solutions for this educational diabetes webinar.
URL:https://www.diabetessociety.com.au/event/updates-on-the-use-of-sglt2i-in-type-2-diabetes-complications-management/
LOCATION:VIC
CATEGORIES:ADS Educational Events,General,Virtual Event
ATTACH;FMTTYPE=image/png:https://www.diabetessociety.com.au/wp-content/uploads/2025/03/ADS-Webinar_27-Mar-2025.png
ORGANIZER;CN="Australian Diabetes Society":MAILTO:admin@diabetessociety.com.au
END:VEVENT
END:VCALENDAR